Delays in the diagnosis and surgical treatment of drug-resistant epilepsy: A cohort study.
barriers to referral
diagnosis delay
drug-resistant epilepsy
epilepsy surgery
neuromodulation
treatment delay
Journal
Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R
Informations de publication
Date de publication:
08 Mar 2024
08 Mar 2024
Historique:
revised:
16
02
2024
received:
12
12
2023
accepted:
26
02
2024
medline:
8
3
2024
pubmed:
8
3
2024
entrez:
8
3
2024
Statut:
aheadofprint
Résumé
Delay in referral for epilepsy surgery of patients with drug-resistant epilepsy (DRE) is associated with decreased quality of life, worse surgical outcomes, and increased risk of sudden unexplained death in epilepsy (SUDEP). Understanding the potential causes of delays in referral and treatment is crucial for optimizing the referral and treatment process. We evaluated the treatment intervals, demographics, and clinical characteristics of patients referred for surgical evaluation at our level 4 epilepsy center in the U.S. Intermountain West. We retrospectively reviewed the records of patients who underwent surgery for DRE between 2012 and 2022. Data collected included patient demographics, DRE diagnosis date, clinical characteristics, insurance status, distance from epilepsy center, date of surgical evaluation, surgical procedure, and intervals between different stages of evaluation. Within our cohort of 185 patients with epilepsy (99 female, 53.5%), the mean ± standard deviation (SD) age at surgery was 38.4 ± 11.9 years. In this cohort, 95.7% of patients had received definitive epilepsy surgery (most frequently neuromodulation procedures) and 4.3% had participated in phase 2 intracranial monitoring but had not yet received definitive surgery. The median (1st-3rd quartile) intervals observed were 10.1 (3.8-21.5) years from epilepsy diagnosis to DRE diagnosis, 16.7 (6.5-28.4) years from epilepsy diagnosis to surgery, and 1.4 (0.6-4.0) years from DRE diagnosis to surgery. We observed significantly shorter median times from epilepsy diagnosis to DRE diagnosis (p < .01) and epilepsy diagnosis to surgery (p < .05) in patients who traveled further for treatment. Patients with public health insurance had a significantly longer time from DRE diagnosis to surgery (p < .001). Both shorter distance traveled to our epilepsy center and public health insurance were predictive of delays in diagnosis and treatment intervals. Timely referral of patients with DRE to specialized epilepsy centers for surgery evaluation is crucial, and identifying key factors that may delay referral is paramount to optimizing surgical outcomes.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NINDS NIH HHS
ID : NS115723
Pays : United States
Informations de copyright
© 2024 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
Références
Sheikh SR, Kattan MW, Steinmetz M, Singer ME, Udeh BL, Jehi L. Cost-effectiveness of surgery for drug-resistant temporal lobe epilepsy in the US. Neurology. 2019;95(10):e1404-e1416. https://doi.org/10.1212/wnl.0000000000010185
Begley CE, Famulari M, Annegers JF, Lairson DR, Reynolds TF, Coan S, et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia. 2000;41(3):342-351. https://doi.org/10.1111/j.1528-1157.2000.tb00166.x
Farhidvash F, Singh P, Abou-Khalil B, Arain A. Patients visiting the emergency room for seizures: insurance status and clinic follow-up. Seizure. 2009;18(9):644-647. https://doi.org/10.1016/j.seizure.2009.08.001
Engel J, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307(9):922-930. https://doi.org/10.1001/jama.2012.220
Heck CN, King-Stephens D, Massey AD, Nair DR, Jobst BC, Barkley GL, et al. Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS system pivotal trial. Epilepsia. 2014;55(3):432-441. https://doi.org/10.1111/epi.12534
Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311-318. https://doi.org/10.1056/nejm200108023450501
Benbadis SR, Heriaud L, Tatum WO, Vale FL. Epilepsy surgery, delays and referral patterns-are all your epilepsy patients controlled? Seizure. 2003;12(3):167-170. https://doi.org/10.1016/s1059-1311(02)00320-5
Haneef Z, Stern J, Dewar S, Engel J. Referral pattern for epilepsy surgery after evidence-based recommendations. Neurology. 2010;75(8):699-704. https://doi.org/10.1212/wnl.0b013e3181eee457
Bernstein J, Kashyap S, Kortz MW, Zakhary B, Takayanagi A, Toor H, et al. Utilization of epilepsy surgery in the United States: a study of the National Inpatient Sample investigating the roles of race, socioeconomic status, and insurance. Surg Neurol Int. 2021;12:546. https://doi.org/10.25259/sni_824_2021
Samanta D, Ostendorf AP, Willis E, Singh R, Gedela S, Arya R, et al. Underutilization of epilepsy surgery: part I: a scoping review of barriers. Epilepsy Behav. 2021;117:107837. https://doi.org/10.1016/j.yebeh.2021.107837
Jackson HN, Gadgil N, Pan IW, Clarke DF, Wagner KM, Cronkite CA, et al. Sociodemographic factors in pediatric epilepsy surgery. Pediatr Neurol. 2020;107:71-76. https://doi.org/10.1016/j.pediatrneurol.2019.09.002
Solli E, Colwell NA, Say I, Houston R, Johal AS, Pak J, et al. Deciphering the surgical treatment gap for drug-resistant epilepsy (DRE): a literature review. Epilepsia. 2020;61(7):1352-1364. https://doi.org/10.1111/epi.16572
Burneo JG, Shariff SZ, Liu K, Leonard S, Saposnik G, Garg AX. Disparities in surgery among patients with intractable epilepsy in a universal health system. Neurology. 2016;86(1):72-78. https://doi.org/10.1212/wnl.0000000000002249
Jr JE. Why is there still doubt to cut it out? Epilepsy Curr. 2013;13(5):198-204. https://doi.org/10.5698/1535-7597-13.5.198
Hill CE, Raab J, Roberts D, Lucas T, Pollard J, Kheder A, et al. Addressing barriers to surgical evaluation for patients with epilepsy. Epilepsy Behav. 2018;86:1-5. https://doi.org/10.1016/j.yebeh.2018.07.003
Kiehna EN, Bollo RJ. Editorial. When in doubt, should we still cut it out? Neurosurg Focus. 2018;45(3):E10. https://doi.org/10.3171/2018.7.focus18348
Blumcke I, Spreafico R, Haaker G, Coras R, Kobow K, Bien CG, et al. Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med. 2017;377(17):1648-1656. https://doi.org/10.1056/nejmoa1703784
Shlobin NA, Campbell JM, Rosenow JM, Rolston JD. Ethical considerations in the surgical and neuromodulatory treatment of epilepsy. Epilepsy Behav. 2022;127:108524. https://doi.org/10.1016/j.yebeh.2021.108524
Samanta D, Hoyt ML, Perry MS. Healthcare professionals' knowledge, attitude, and perception of epilepsy surgery: a systematic review. Epilepsy Behav. 2021;122:108199. https://doi.org/10.1016/j.yebeh.2021.108199
Armour EA, Yiu AJ, Shrey DW, Reddy SB. Underrepresented populations in pediatric epilepsy surgery. Semin Pediatr Neurol. 2021;39:100916. https://doi.org/10.1016/j.spen.2021.100916
Thompson AC, Ivey SL, Lahiff M, Betjemann JP. Delays in time to surgery for minorities with temporal lobe epilepsy. Epilepsia. 2014;55(9):1339-1346. https://doi.org/10.1111/epi.12700
Erba G, Messina P, Pupillo E, Beghi E, Group TOP. Acceptance of epilepsy surgery in the pediatric age - what the parents think and what the doctors can do. Epilepsy Behav. 2013;29(1):112-120. https://doi.org/10.1016/j.yebeh.2013.05.039
Rubinger L, Chan C, Andrade D, Go C, Smith ML, Snead OC, et al. Socioeconomic status influences time to surgery and surgical outcome in pediatric epilepsy surgery. Epilepsy Behav. 2016;55:133-138. https://doi.org/10.1016/j.yebeh.2015.12.007
Simasathien T, Vadera S, Najm I, Gupta A, Bingaman W, Jehi L. Improved outcomes with earlier surgery for intractable frontal lobe epilepsy. Ann Neurol. 2013;73(5):646-654. https://doi.org/10.1002/ana.23862
Edelvik A, Rydenhag B, Olsson I, Flink R, Kumlien E, Källén K, et al. Long-term outcomes of epilepsy surgery in Sweden a national prospective and longitudinal study. Neurology. 2013;81(14):1244-1251. https://doi.org/10.1212/wnl.0b013e3182a6ca7b
Pelliccia V, Deleo F, Gozzo F, Sartori I, Mai R, Cossu M, et al. Early and late epilepsy surgery in focal epilepsies associated with long-term epilepsy-associated tumors. J Neurosurg. 2017;127(5):1147-1152. https://doi.org/10.3171/2016.9.jns161176
Jette N, Quan H, Tellez-Zenteno JF, Macrodimitris S, Hader WJ, Sherman EMS, et al. Development of an online tool to determine appropriateness for an epilepsy surgery evaluation. Neurology. 2012;79(11):1084-1093. https://doi.org/10.1212/wnl.0b013e3182698c4c
Peterson K, LaRoche S, Cummings T, Woodard V, Moise AM, Clary HM. Addressing the epilepsy surgery gap: impact of community/tertiary epilepsy center collaboration. Epilepsy Behav Rep. 2020;14:100398. https://doi.org/10.1016/j.ebr.2020.100398